BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Blumenthal KG, Fox LP, Freeman EE. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol 2021;85:46-55. [PMID: 33838206 DOI: 10.1016/j.jaad.2021.03.092] [Cited by in Crossref: 415] [Cited by in F6Publishing: 255] [Article Influence: 207.5] [Reference Citation Analysis]
Number Citing Articles
1 Russo D, Accarino R, Varricchio S, Franca RA, Potestio L, Patruno C, Napolitano M, Mascolo M. Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review. Pathol Res Pract 2022;242:154300. [PMID: 36638589 DOI: 10.1016/j.prp.2022.154300] [Reference Citation Analysis]
2 Martora F, Villani A, Marasca C, Fabbrocini G, Ruggiero A. Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. Australas J Dermatol 2023. [PMID: 36683345 DOI: 10.1111/ajd.13984] [Reference Citation Analysis]
3 Wu P, Li C, Chang Y, Chen C, Wu C, Ma S. Management of Atopic Dermatitis During the COVID-19 Pandemic: Key Questions and Review of the Current Evidence. Dermatitis® 2023. [DOI: 10.1089/derm.2022.29019.pwu] [Reference Citation Analysis]
4 Ferreira-da-silva R, Ribeiro-vaz I, Silva AM, Nunes F, Morato M, Polónia JJ, Guedes P. Delayed Extensive Local Reaction to the mRNA-1273 Vaccine against SARS-CoV-2: A Case Report. Journal of Pharmacology and Pharmacotherapeutics 2023. [DOI: 10.1177/0976500x221147748] [Reference Citation Analysis]
5 Nakashima C, Kato M, Otsuka A. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. J Dermatol 2023. [PMID: 36636825 DOI: 10.1111/1346-8138.16651] [Reference Citation Analysis]
6 Kuziez L, Eleiwa TK, Chauhan MZ, Sallam AB, Elhusseiny AM, Saeed HN. Corneal Adverse Events Associated with SARS-CoV-2/COVID-19 Vaccination: A Systematic Review. Vaccines (Basel) 2023;11. [PMID: 36680010 DOI: 10.3390/vaccines11010166] [Reference Citation Analysis]
7 Liu YA, Dai J, Nagarajan P, Torres-Cabala CA, Aung PP, Prieto VG, Cho WC. Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review. Am J Dermatopathol 2023. [PMID: 36626570 DOI: 10.1097/DAD.0000000000002369] [Reference Citation Analysis]
8 Cazzato G. Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical/Dermoscopical Findings: Where We Are and Where We Will Go. Vaccines (Basel) 2023;11. [PMID: 36679997 DOI: 10.3390/vaccines11010152] [Reference Citation Analysis]
9 Li Q, Shi Y, Shi S, Hu H, Liu L, Mao Y, Liu Y, Li Q. Cutaneous reactions after COVID-19 vaccination: A single-center retrospective study in China with 61 cases. J Cosmet Dermatol 2023. [PMID: 36606402 DOI: 10.1111/jocd.15586] [Reference Citation Analysis]
10 Ahouach B, Diaz E, Bertin B, Ben Said B, Combret S, Grandvuillemin A, Petitpain N, Rabier MB, Thomas L, Trenque T, Ingen-Housz-Oro S, Lebrun-Vignes B. Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase. J Eur Acad Dermatol Venereol 2023. [PMID: 36606525 DOI: 10.1111/jdv.18845] [Reference Citation Analysis]
11 Agustin M, Trifitriana M, Danarti R. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review. BMC Infect Dis 2023;23:7. [PMID: 36609222 DOI: 10.1186/s12879-022-07973-4] [Reference Citation Analysis]
12 Miao G, Chen Z, Cao H, Wu W, Chu X, Liu H, Zhang L, Zhu H, Cai H, Lu X, Shi J, Liu Y, Feng T. From Immunogen to COVID-19 Vaccines: Prospects for The Post-pandemic Era. Biomedicine & Pharmacotherapy 2023. [DOI: 10.1016/j.biopha.2022.114208] [Reference Citation Analysis]
13 Han TY, Shim DH, Lee YJ, Lee YB, Koo HYR, Shin MK, Kim TE, Jang YH, Bang JS, Kook HD, Ahn J, Jung HJ, Na CH. Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study. Ann Dermatol 2023;35. [DOI: 10.5021/ad.22.118] [Reference Citation Analysis]
14 Bressler MY, Delgado AR, Charlie N. Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV. JAAD Case Rep 2023;31:118-20. [PMID: 36406337 DOI: 10.1016/j.jdcr.2022.11.007] [Reference Citation Analysis]
15 Yelich A, Dazé R, Moon S. An asymmetric morbilliform eruption in an adult male. JAAD Case Rep 2023;31:142-5. [PMID: 36590078 DOI: 10.1016/j.jdcr.2022.11.037] [Reference Citation Analysis]
16 Martora F, Fornaro L, Picone V, Marasca D, Gargiulo M, Annunziata MC, Fabbrocini G, Marasca C. Herpes zoster and alopecia areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects. J Cosmet Dermatol 2023;22:36-8. [PMID: 36239007 DOI: 10.1111/jocd.15465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chatterjee A, Chakravarty A. Neurological Complications Following COVID-19 Vaccination. Curr Neurol Neurosci Rep 2023;23:1-14. [PMID: 36445631 DOI: 10.1007/s11910-022-01247-x] [Reference Citation Analysis]
18 Liao Y, Huang H, Wu C, Lee J, Hsu C. Lymphocytic thrombophilic arteritis following mRNA-1273 severe acute respiratory syndrome coronavirus 2 vaccination: A case report and review of the literature. Dermatol Sin 2023;0:0. [DOI: 10.4103/ds.ds-d-22-00031] [Reference Citation Analysis]
19 Özdinç A, Değer MS, Atak M, Demir İ. Talking about the Vaccine after the Pandemic: A Cross-Sectional Study among Youth in Turkey and Ethical Issues. Vaccines (Basel) 2023;11. [PMID: 36679949 DOI: 10.3390/vaccines11010104] [Reference Citation Analysis]
20 Serrano Gomez Y, Grella B, Wang H. A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination. Case Rep Dermatol Med 2022;2022:4267930. [PMID: 36624889 DOI: 10.1155/2022/4267930] [Reference Citation Analysis]
21 Nakahara Y, Yamane M, Sunada M, Aoyama Y. SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid. J Dermatol 2023;50:162-5. [PMID: 36578130 DOI: 10.1111/1346-8138.16687] [Reference Citation Analysis]
22 Öner Ü, Aktaş A. Cutaneous reactions after CoronaVac and BioNTech vaccines. J Cosmet Dermatol 2022. [PMID: 36575893 DOI: 10.1111/jocd.15573] [Reference Citation Analysis]
23 Oguz Topal I, Tokmak A, Kurmuş GI, Kalkan G, Demirseren DD, Tosun M, Emre S, Özkök Akbulut T, Kaya Özden H, Koska MC, Külcü Çakmak S, Kutlu Ö, Mutlu E, Gür Aksoy G, Topaloğlu Demir F, Karadağ AS. Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey. J Cosmet Dermatol 2022. [PMID: 36575896 DOI: 10.1111/jocd.15570] [Reference Citation Analysis]
24 Gogia P, Tanni F, Coca-Guzman J, Chen N, Huang Y. Case report: A rare case of Rosai-Dorfman-Destombes disease after the COVID-19 infection. Front Med (Lausanne) 2022;9:1073767. [PMID: 36600887 DOI: 10.3389/fmed.2022.1073767] [Reference Citation Analysis]
25 Avallone G, Maronese CA, Conforti C, Fava P, Gargiulo L, Marzano AV, Massone C, Mastorino L, Paradisi A, Pileri A, Quaglino P, Rizzo N, Ribero S, Roccuzzo G, Tavoletti G, Vignoli CA, Zalaudek I, Berti E, Alberti-Violetti S. Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals. J Eur Acad Dermatol Venereol 2022. [PMID: 36469002 DOI: 10.1111/jdv.18806] [Reference Citation Analysis]
26 Kara A, Bay EY, Topal IO, Yalcin O. Development of Vitiligo After COVID-19 Vaccination. Sisli Etfal Hastan Tip Bul 2022;56:572-3. [PMID: 36660379 DOI: 10.14744/SEMB.2022.63139] [Reference Citation Analysis]
27 Ahmad Hosseinzadeh, Kamyar Ebrahimi, Reza Shahriarirad, Farzad Dalfardi. Lower limb lymphedema and cellulitis as a complication of COVID‐19 vaccine: A case report. Clin Case Rep 2022;10:e6317. [PMID: 36540881 DOI: 10.1002/ccr3.6317] [Reference Citation Analysis]
28 Bresler SC, Menge TD, Tejasvi T, Carty SA, Hristov AC. Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: A reactive lymphomatoid papulosis-like eruption and a bona fide lymphoma. J Cutan Pathol 2022. [PMID: 36437812 DOI: 10.1111/cup.14371] [Reference Citation Analysis]
29 Esfandiari N, Benson P, Morley K. Wolf's isotopic response: A case of dermatomal granuloma annulare after COVID‐19 vaccination. JEADV Clinical Practice 2022. [DOI: 10.1002/jvc2.90] [Reference Citation Analysis]
30 Oktarina DAM, Fadhal I, Febriana SA, Kusuma AD. A rapid review of the prevalence and onset of urticaria triggered by COVID-19 vaccine. F1000Res 2022;11:1442. [DOI: 10.12688/f1000research.127886.1] [Reference Citation Analysis]
31 Gao JC, Huang A, Desai A, Safai B, Marmon S. “COVID toes”: A true viral phenomenon or a diagnosis without a leg to stand on? JAAD International 2022;9:1-6. [DOI: 10.1016/j.jdin.2022.06.012] [Reference Citation Analysis]
32 Kim MJ, Kim JW, Na JI. Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech). Dermatol Ther 2022;35:e15915. [PMID: 36209375 DOI: 10.1111/dth.15915] [Reference Citation Analysis]
33 Franceschi J, Darrigade A, Sanchez‐pena P, Legrain‐lifermann V, Milpied B. Pyoderma gangrenosum after mRNA‐based SARS‐CoV ‐2 vaccine. Acad Dermatol Venereol 2022;36. [DOI: 10.1111/jdv.18389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Rahmanian E, Alikhani M, Loghman M, Beikmohamadi Hezaveh S, Zangeneh S, Shahriarirad R, Faezi ST, Nejadhosseinian M. COVID ‐19 vaccine‐induced vasculitis in a patient with sarcoidosis: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6501] [Reference Citation Analysis]
35 El-Qushayri AE, Nardone B. Psoriasis exacerbation after COVID-19 vaccines: A brief report of the reported cases. Dermatol Ther 2022;35:e15900. [PMID: 36200490 DOI: 10.1111/dth.15900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Özdemir Ö. Delayed nonlocal cutaneous reactions after inactive COVID-19 vaccinations. J Cosmet Dermatol 2022;21:6574. [PMID: 36217565 DOI: 10.1111/jocd.15455] [Reference Citation Analysis]
37 Gay J, Trivedi N, Simpson S, Grider D. Persistent Rash After COVID-19 Vaccination: Answer. The American Journal of Dermatopathology 2022;44:1005-1006. [DOI: 10.1097/dad.0000000000002299] [Reference Citation Analysis]
38 Ahmed F, Memon N, Haque A. Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report. JMIR Dermatol 2022;5:e41739. [PMID: 36504544 DOI: 10.2196/41739] [Reference Citation Analysis]
39 Pesqué D, Pujol RM, Marcantonio O, Vidal-Navarro A, Ramada JM, Arderiu-Formentí A, Albalat-Torres A, Serra C, Giménez-Arnau AM. Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm. Vaccines (Basel) 2022;10. [PMID: 36560458 DOI: 10.3390/vaccines10122048] [Reference Citation Analysis]
40 Kim Y, Shim HS, Jeong H, Park Y. Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report. The International Journal of Lower Extremity Wounds 2022. [DOI: 10.1177/15347346221141173] [Reference Citation Analysis]
41 McClelland P, Gray BH. Cilostazol as a Treatment for COVID Toes: A Case Report. Ann Vasc Surg 2022:S0890-5096(22)00734-8. [PMID: 36442709 DOI: 10.1016/j.avsg.2022.10.013] [Reference Citation Analysis]
42 James P. Pham. Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine. Int J Womens Dermatol 2022;8. [PMID: 36415850 DOI: 10.1097/JW9.0000000000000058] [Reference Citation Analysis]
43 Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. CCID 2022;Volume 15:2369-2382. [DOI: 10.2147/ccid.s388245] [Reference Citation Analysis]
44 Miller M, Tracey M, Simpson M, Mikita C. Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination. Allergy Asthma Proc 2022;43:555-8. [PMID: 36335420 DOI: 10.2500/aap.2022.43.220058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Çakıcı ÖA, Güder S, Salman A, Ergun T. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings. Indian J Dermatol Venereol Leprol 2022;88:814-6. [PMID: 36332096 DOI: 10.25259/IJDVL_165_2022] [Reference Citation Analysis]
46 El-behaedi S, Ng S, Goyal PK, Choi JN. Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy. JAAD Case Reports 2022;29:48-50. [DOI: 10.1016/j.jdcr.2022.08.043] [Reference Citation Analysis]
47 Kultawanich K, Sampattavanich N. Local bullous reaction as a cutaneous reaction after m RNA ‐boosted vaccination in a post‐ COVID patient. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6610] [Reference Citation Analysis]
48 Junfeng Zhang, Jiajia Cao, Qing Ye. Renal Side Effects of COVID-19 Vaccination. Vaccines (Basel) 2022;10:1783. [PMID: 36366292 DOI: 10.3390/vaccines10111783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Himed S, Gray A, Awethe Z, Libson K, Kaffenberger BH, Korman AM, Trinidad JCL. SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist. Curr Derm Rep. [DOI: 10.1007/s13671-022-00374-5] [Reference Citation Analysis]
50 Noseda R, Müller L, Stammschulte T, Bertoli R, Ceschi A. Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports. Eur J Clin Pharmacol 2022. [PMID: 36255481 DOI: 10.1007/s00228-022-03404-0] [Reference Citation Analysis]
51 Ben-Fredj N, Chahed F, Ben-Fadhel N, Mansour K, Ben-Romdhane H, Mabrouk RSE, Chadli Z, Ghedira D, Belhadjali H, Chaabane A, Aouam K. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation. Eur J Clin Pharmacol 2022. [PMID: 36255482 DOI: 10.1007/s00228-022-03399-8] [Reference Citation Analysis]
52 Singh R, Freeman EE. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin. Curr Derm Rep. [DOI: 10.1007/s13671-022-00370-9] [Reference Citation Analysis]
53 Wan V, Chen D, Shiau CJ, Jung GW. Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review. SAGE Open Med Case Rep 2022;10:2050313X221131868. [PMID: 36274858 DOI: 10.1177/2050313X221131868] [Reference Citation Analysis]
54 Li HO, Lipson J. New mycosis fungoides-like lymphomatoid reaction following COVID-19 vaccination: A case report. SAGE Open Med Case Rep 2022;10:2050313X221131859. [PMID: 36267336 DOI: 10.1177/2050313X221131859] [Reference Citation Analysis]
55 Wilms L, Weßollek K, Peeters TB, Yazdi AS. Infektionen mit Herpes‐simplex‐ und Varizella‐zoster‐Virus. J Deutsche Derma Gesell 2022;20:1327-1353. [DOI: 10.1111/ddg.14917_g] [Reference Citation Analysis]
56 Wilms L, Weßollek K, Peeters TB, Yazdi AS. Infections with Herpes simplex and Varicella zoster virus. J Deutsche Derma Gesell 2022;20:1327-1351. [DOI: 10.1111/ddg.14917] [Reference Citation Analysis]
57 Pandit T, Pandit R, Goyal L. Uncommon Side Effects of COVID-19 Vaccination in the Pediatric Population. Cureus 2022;14:e30276. [PMID: 36258808 DOI: 10.7759/cureus.30276] [Reference Citation Analysis]
58 Taha Gul Shaikh, Summaiyya Waseem, Syed Hassan Ahmed, Nashwa Abdul Qadir, Vincenzo Piccolo. SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far? Dermatol Pract Concept 2022;12:e2022170. [PMID: 36534559 DOI: 10.5826/dpc.1204a170] [Reference Citation Analysis]
59 Laura Macca, Lucia Peterle, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri. Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo. Vaccines (Basel) 2022;10:1647. [PMID: 36298511 DOI: 10.3390/vaccines10101647] [Reference Citation Analysis]
60 Janßen S, Homey B, Meller S. Gianotti-crosti syndrome after COVID-19 vaccination. J Eur Acad Dermatol Venereol 2023;37:e147-8. [PMID: 36177535 DOI: 10.1111/jdv.18626] [Reference Citation Analysis]
61 Filon FL, Lazzarato I, Patriarca E, Iavernig T, Peratoner A, Perri G, Ponis G, Rocco G, Cegolon L. Allergic Reactions to COVID-19 Vaccination in High-Risk Allergic Patients: The Experience of Trieste University Hospital (Northeastern Italy). Vaccines 2022;10:1616. [DOI: 10.3390/vaccines10101616] [Reference Citation Analysis]
62 Ständer S, Zirpel H, Bujoreanu F, Tatu AL, Ludwig RJ, Thaçi D. Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis–A case series and mini review. Front Med 2022;9. [DOI: 10.3389/fmed.2022.995150] [Reference Citation Analysis]
63 Alghamdi FA, Khayyat ST, Alshareef MM, Felemban W. New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine. Case Reports in Dermatological Medicine 2022;2022:1-4. [DOI: 10.1155/2022/2082445] [Reference Citation Analysis]
64 Ahmed F, Memon N, Haque A. Multiple keratoacanthomas following the Moderna mRNA-1273 Covid-19 vaccination resolved with 5-FU treatment: Case Report (Preprint).. [DOI: 10.2196/preprints.41739] [Reference Citation Analysis]
65 Tassone F, Cappilli S, Antonelli F, Zingarelli R, Chiricozzi A, Peris K. Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study. Vaccines 2022;10:1467. [DOI: 10.3390/vaccines10091467] [Reference Citation Analysis]
66 Kobyashi Y, Adachi T, Arakawa H, Takeuchi M, Inazumi T. Erythema multiforme following vaccination for SARS-CoV-2: Report of a case and review of the literature - Secondary Publication. Australas J Dermatol 2022. [PMID: 36057958 DOI: 10.1111/ajd.13917] [Reference Citation Analysis]
67 Iijima S, Enami C, Sato M, Tsunoda T, Otoyama K. Neutrophilic dermatosis with necrobiotic changes as an unusual manifestation after the first shot of a COVID ‐19 mRNA vaccine together with a high fever and liver injury. J Cutaneous Imm & Allergy 2022. [DOI: 10.1002/cia2.12279] [Reference Citation Analysis]
68 Mahdiabadi S, Rezaei N. Anaphylaxis and allergic reactions to COVID‐19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunity. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Gimeno Castillo J, Garrapiz Borderías I. Urticaria aguda de aparición retardada tras tercera vacuna contra SARS-CoV-2. Medicina de Familia SEMERGEN 2022;48:437-438. [DOI: 10.1016/j.semerg.2022.03.001] [Reference Citation Analysis]
70 Markovitz NH, Pedersen E, Sachs DL, Bresler SC. Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19. JAAD Case Rep 2022;27:156-8. [PMID: 35845347 DOI: 10.1016/j.jdcr.2022.07.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Girolami I, Eisendle K, Kluge RW, Hanspeter E, Eccher A, Vizziello L, Zampieri P, Mazzoleni G. Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine. Pathologica 2022;114:322-325. [DOI: 10.32074/1591-951x-746] [Reference Citation Analysis]
72 Corey KB, Koo G, Phillips EJ. Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2254-2266. [DOI: 10.1016/j.jaip.2022.04.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Wu PC, Huang IH, Wang CW, Tsai CC, Chung WH, Chen CB. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review. Am J Clin Dermatol 2022. [PMID: 36048409 DOI: 10.1007/s40257-022-00721-z] [Reference Citation Analysis]
74 Katsuie S, Nakamura K, Ogawa E, Arakura F, Okuyama R. Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination. Cureus 2022. [DOI: 10.7759/cureus.28604] [Reference Citation Analysis]
75 Wang R, Chiang W, Chiu C, Wu K, Lin C, Kao Y, Chuu C, Chan J, Hsiao P. Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review. Vaccines 2022;10:1412. [DOI: 10.3390/vaccines10091412] [Reference Citation Analysis]
76 Yamamoto M, Kase M, Sano H, Kamijima R, Sano S. Persistent varicella zoster virus infection following mRNA COVID ‐19 vaccination was associated with the presence of encoded spike protein in the lesion. J Cutaneous Imm & Allergy 2022. [DOI: 10.1002/cia2.12278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Al‐muqarrab FJ, Alakloby OM, Al Ameer MA, Alhajri AM. Cutaneous reactions post‐COVID‐19 vaccination. Case series and literature review. JEADV Clinical Practice 2022. [DOI: 10.1002/jvc2.56] [Reference Citation Analysis]
78 Harada F, Yamamoto K, Matsuda T, Yamamoto C, Tani Y, Ohnishi M, Takita M, Tanimoto T, Kami M, Shineha R. Allergic reaction to anisakis-contaminated fish after the first administration of BNT162b2 mRNA vaccine: a case report. Gastroenterol Rep (Oxf) 2022;10:goac034. [PMID: 35966631 DOI: 10.1093/gastro/goac034] [Reference Citation Analysis]
79 Shawky A, Elrewiny EM, Gharib K, Sallam M, Mansour M, Rageh MA. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination. Int J Dermatol 2023;62:221-4. [PMID: 35959522 DOI: 10.1111/ijd.16391] [Reference Citation Analysis]
80 Oueijan RI, Hill OR, Ahiawodzi PD, Fasinu PS, Thompson DK. Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review. Medicines 2022;9:43. [DOI: 10.3390/medicines9080043] [Reference Citation Analysis]
81 Trepanowski N, Coleman EL, Melson G, Brem CE, Lam CS. Erythrodermic psoriasis after COVID-19 vaccination. JAAD Case Rep 2022. [PMID: 35966353 DOI: 10.1016/j.jdcr.2022.07.041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Casale JJ, Muse ME, Snow TJ, Gould KP, Depcik-smith ND. Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination. Case Reports in Dermatological Medicine 2022;2022:1-3. [DOI: 10.1155/2022/1469410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Davila-fernandez G, Sanchez-moreno GV, Madrigal-burgaleta R. Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2166-2168.e1. [DOI: 10.1016/j.jaip.2022.04.026] [Reference Citation Analysis]
84 Hu Y, Zhang J, Zhao Y. New Onset of Severe Plaque Psoriasis Following COVID-19 Vaccination: A Case Report. CCID 2022;Volume 15:1485-7. [DOI: 10.2147/ccid.s376555] [Reference Citation Analysis]
85 López Pérez V. [Translated article] COVID-19 and Dermal Fillers: Should We Really Be Concerned? Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.08.013] [Reference Citation Analysis]
86 Karatzios C, Scuccimarri R, Chédeville G, Basfar W, Bullard J, Stein DR. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children. Pediatrics 2022;150:e2021055956. [PMID: 35614536 DOI: 10.1542/peds.2021-055956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
87 Martinez-reviejo R, Tejada S, Adebanjo GA, Chello C, Machado MC, Parisella FR, Campins M, Tammaro A, Rello J. Varicella-Zoster Virus Reactivation following Severe Acute Respiratory Syndrome Coronavirus 2 vaccination or infection: New Insights. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.07.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Aashish, Rai A, Khatri G, Priya, Hasan MM. Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder. Annals of Medicine and Surgery 2022;80:104266. [DOI: 10.1016/j.amsu.2022.104266] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Sinha S, Tripathy S. COVID-19 Vaccine-associated Thrombosis (Disseminated Intravascular Thrombosis) with Rare Cutaneous Involvement. Indian Journal of Critical Care Medicine 2022;26:963-5. [DOI: 10.5005/jp-journals-10071-24282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Sydow E, Mustafa AS, Hanif A, Tunio J, Hanif SNM. Recent Updates on mRNA Vaccines. Vaccines (Basel) 2022;10:1209. [PMID: 36016096 DOI: 10.3390/vaccines10081209] [Reference Citation Analysis]
91 Olisova O, Vovdenko KA, Mak DV, Mishin SA. Polymorphic dermal vasculitis flare up after COVID-19: case report. Russian Journal of Skin and Venereal Diseases 2022;24:573-580. [DOI: 10.17816/dv83044] [Reference Citation Analysis]
92 Martins-Filho PR, Tenório MDL. Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2. EXCLI J 2022;21:1015-8. [PMID: 36172068 DOI: 10.17179/excli2022-5216] [Reference Citation Analysis]
93 Bin Rubaian NF, Almuhaidib SR, Aljarri SA, Alamri AS. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl. Cureus 2022. [DOI: 10.7759/cureus.27108] [Reference Citation Analysis]
94 Cross DE, Garritano J, Zubek AE, Little AJ. Pruritic annular erythematous eruption after receiving the COVID-19 vaccine. International Journal of Women’s Dermatology 2022;8:e033. [DOI: 10.1097/jw9.0000000000000033] [Reference Citation Analysis]
95 Antoñanzas J, Rodríguez-Garijo N, Estenaga Á, Morelló-Vicente A, España A, Aguado L. Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review. Dermatol Ther 2022;:e15709. [PMID: 35811413 DOI: 10.1111/dth.15709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Nanamori H, Sawada Y, Sato S, Hara R, Minokawa Y, Sugino H, Saito‐sasaki N, Yamamoto K, Okada E, Nakamura M. Prior antihistamine agent successfully impaired cutaneous adverse reactions to COVID ‐19 vaccine. J Cutaneous Imm & Allergy 2022. [DOI: 10.1002/cia2.12248] [Reference Citation Analysis]
97 Amjad MA, Hamid Z, Ochieng P, Li S. COVID-19 Vaccine Booster-Induced Dermatographism. Cureus 2022. [DOI: 10.7759/cureus.26566] [Reference Citation Analysis]
98 Copaescu AM, Rosa Duque JS, Phillips EJ. What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later. Ann Allergy Asthma Immunol 2022;129:40-51. [PMID: 35390476 DOI: 10.1016/j.anai.2022.03.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Valverde-lópez J, Rodríguez-saldaña J. Reactivación del virus varicela zóster tras la vacunación contra la COVID-19. Piel 2022;37:S10-S12. [DOI: 10.1016/j.piel.2022.03.007] [Reference Citation Analysis]
100 Garcia-blanco L, Celorio-murillo W, Delgado V. Vasculitis leucocitoclástica asociada a la vacuna ARNm contra la COVID-19. Piel 2022;37:S18-S20. [DOI: 10.1016/j.piel.2022.04.001] [Reference Citation Analysis]
101 Padovese V. Stepping up efforts to support Ukrainian refugees: the role of the dermatological community. Br J Dermatol 2022;187:1-2. [PMID: 35781644 DOI: 10.1111/bjd.21606] [Reference Citation Analysis]
102 Martinez-Cabriales SA, Shear NH. Comment on "Toxic epidermal necrolysis (TEN) after first dose of Pfizer (BNT162b2) vaccination and pharmacogenomic-based-point-care support: First case report in pediatric and review of literature". Pediatr Dermatol 2022;39:671-2. [PMID: 36000935 DOI: 10.1111/pde.14987] [Reference Citation Analysis]
103 Magdalena Dumitru I. Side Effects of the COVID-19 Vaccines. COVID-19 Vaccines - Current State and Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.105668] [Reference Citation Analysis]
104 Ruiz-Villaverde R, Rivera-Izquierdo M, Gil-Villalba A, Pegalajar-García MD, Pérez-Rojas J, Soler-Iborte E, Valero-Ubierna MC. Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workers. Int J Dermatol 2022. [PMID: 35775137 DOI: 10.1111/ijd.16336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Hernandez Quiroz E, Kauffman CL, Kupiec-Banasikowska A. Erythema Multiforme Following Hepatitis A and Pneumococcal Vaccinations. Yale J Biol Med 2022;95:213-5. [PMID: 35782476] [Reference Citation Analysis]
106 Pendlebury GA, Oro P, Haynes W, Merideth D, Bartling S, Bongiorno MA. The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review. Dermatopathology (Basel) 2022;9:212-43. [PMID: 35892480 DOI: 10.3390/dermatopathology9030027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
107 Mouliou DS, Dardiotis E. Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns. Diagnostics 2022;12:1555. [DOI: 10.3390/diagnostics12071555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
108 Escudero C, Prieto-montaño P, Audicana MT. Adverse Reactions to Anti-Infective Vaccines: an Emerging Problem in the COVID-19 Era. Curr Treat Options Allergy. [DOI: 10.1007/s40521-022-00311-8] [Reference Citation Analysis]
109 de Lorenzi C, Kaya G, Toutous Trellu L. Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine. Dermatopathology (Basel) 2022;9:203-6. [PMID: 35892478 DOI: 10.3390/dermatopathology9030025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Dong C, Yu Z, Quan X, Wei S, Wang J, Ma X. No Differences in Wound Healing and Scar Formation Were Observed in Patients With Different COVID-19 Vaccination Intervals. Front Public Health 2022;10:883113. [PMID: 35719612 DOI: 10.3389/fpubh.2022.883113] [Reference Citation Analysis]
111 Potestio L, Genco L, Villani A, Marasca C, Fabbrocini G, Fornaro L, Ruggiero A, Martora F. Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study'. by Bawane J et al. J Eur Acad Dermatol Venereol 2022. [PMID: 35723893 DOI: 10.1111/jdv.18341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
112 Singh R, Cohen JL, Astudillo M, Harris JE, Freeman EE. Vitiligo of the arm after COVID-19 vaccination. JAAD Case Rep 2022. [PMID: 35756074 DOI: 10.1016/j.jdcr.2022.06.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Shah H, Busquets AC. Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series. Cureus 2022. [DOI: 10.7759/cureus.25987] [Reference Citation Analysis]
114 Ryoo Y, Kim Y, Yun J, Kim S. A Case of Leukocytoclastic Vasculitis Following COVID-19 Vaccination. Keimyung Med J 2022;41:46-49. [DOI: 10.46308/kmj.2022.00010] [Reference Citation Analysis]
115 Paparella R, Tarani L, Properzi E, Costantino F, Saburri C, Lucibello R, Richetta A, Spalice A, Leonardi L. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Ital J Pediatr 2022;48:93. [PMID: 35698236 DOI: 10.1186/s13052-022-01296-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Poizeau F, Triquet L, Dupuy A. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains. Acta Derm Venereol 2022;102:adv00728. [DOI: 10.2340/actadv.v102.888] [Reference Citation Analysis]
117 Barei F, Marletta DA, Marti-Marti I, Maronese CA, Genovese G, Marzano AV. Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273. Dermatol Ther 2022;:e15631. [PMID: 35678474 DOI: 10.1111/dth.15631] [Reference Citation Analysis]
118 Borgia F, Li Pomi F, Alessandrello C, Vaccaro M, Pioggia G, Gangemi S. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection. J Dermatol 2022. [PMID: 35675487 DOI: 10.1111/1346-8138.16482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Higashino T, Yamazaki Y, Senda S, Satou Y, Yonekura Y, Imai K, Arakawa J, Kawano S, Horinosono H, Miura Y. Assessment of Delayed Large Local Reactions After the First Dose of the SARS-CoV-2 mRNA-1273 Vaccine in Japan. JAMA Dermatol 2022. [PMID: 35649530 DOI: 10.1001/jamadermatol.2022.2088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 López Pérez V. COVID y rellenos faciales ¿realmente debemos preocuparnos? Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.05.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Jo E. Adverse Reactions of COVID-19 Vaccines. J Clin Otolaryngol Head Neck Surg 2022;33:92-104. [DOI: 10.35420/jcohns.2022.33.2.92] [Reference Citation Analysis]
122 Li X, Gao L, Tong X, Chan VKY, Chui CSL, Lai FTT, Wong CKH, Wan EYF, Chan EWY, Lau KK, Lau CS, Wong ICK. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong. J Autoimmun 2022;130:102830. [PMID: 35461018 DOI: 10.1016/j.jaut.2022.102830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
123 Stehlin F, Mahdi-aljedani R, Canton L, Monzambani-banderet V, Miauton A, Girard C, Kammermann K, Meylan S, Ribi C, Harr T, Yerly D, Muller YD. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance. Front Allergy 2022;3:818049. [DOI: 10.3389/falgy.2022.818049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Hung S, Preclaro IAC, Chung W, Wang C. Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies. Biomedicines 2022;10:1260. [DOI: 10.3390/biomedicines10061260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Awaya T, Moroi M, Enomoto Y, Kunimasa T, Nakamura M. What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions. Vaccines 2022;10:866. [DOI: 10.3390/vaccines10060866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
126 Gázquez Aguilera EM, Rodríguez García M, Cantón Yebra MT. Cutaneous vasculitis due to COVID-19 vaccination. Med Clin (Barc) 2022;158:493-4. [PMID: 34895746 DOI: 10.1016/j.medcli.2021.09.027] [Reference Citation Analysis]
127 Canu D, Doutre MS. Regression of sarcoidosis skin lesions after receiving the Moderna anti-coronavirus disease 2019 vaccine. J Dermatol 2022. [PMID: 35588231 DOI: 10.1111/1346-8138.16438] [Reference Citation Analysis]
128 Kim Y, Kang J, Lee SG, Kim GT. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement. Z Rheumatol 2022. [PMID: 35587834 DOI: 10.1007/s00393-022-01159-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Russo R, Cozzani E, Micalizzi C, Parodi A. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series. Acta Derm Venereol 2022;102:adv00711. [DOI: 10.2340/actadv.v102.2076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Kalantari Y, Aryanian Z, Mirahmadi SM, Alilou S, Hatami P, Goodarzi A. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles. J Cosmet Dermatol 2022. [PMID: 35534886 DOI: 10.1111/jocd.15071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Bangkara BA, Fatmawati E, Siregar MT, Wirawan V, Wisman W. Managing Higher Education in Pandemic Era in the Challenge of Education Quality and Equity. ji 2022;7:120-138. [DOI: 10.25217/ji.v7i1.2068] [Reference Citation Analysis]
132 Gázquez Aguilera EM, Rodríguez García M, Cantón Yebra MT. Cutaneous vasculitis due to COVID-19 vaccination. Medicina Clínica (English Edition) 2022;158:493-494. [DOI: 10.1016/j.medcle.2021.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Wang CS, Chen HH, Liu SH. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. J Formos Med Assoc 2022;121:1003-7. [PMID: 35012825 DOI: 10.1016/j.jfma.2021.12.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
134 Elkousy HA, Khoriaty JD, Vidal EA, Vincent SJ, Buras BA, Laughlin MS. Adverse events after mRNA vaccine administration from a busy orthopedic practice: a series of four cases. JSES Reviews, Reports, and Techniques 2022;2:186-189. [DOI: 10.1016/j.xrrt.2021.12.003] [Reference Citation Analysis]
135 Hodge B, Daniel CR, Elewski BE. Vaccine Toes Are the New COVID Toes. Skin Appendage Disord 2022;37:1-4. [PMID: 35664444 DOI: 10.1159/000521724] [Reference Citation Analysis]
136 Reinhart M, Metze D, Braun SA. [Skin manifestations of COVID-19 and after COVID-19 vaccination]. Hautarzt 2022. [PMID: 35477785 DOI: 10.1007/s00105-022-04991-w] [Reference Citation Analysis]
137 Virdi G. Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection. Cureus 2022. [DOI: 10.7759/cureus.24461] [Reference Citation Analysis]
138 Diogo P, Correia G, Martins JB, Soares R, Palma PJ, Santos JM, Gonçalves T. Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? Vaccines 2022;10:602. [DOI: 10.3390/vaccines10040602] [Reference Citation Analysis]
139 Desai AD, Shah R, Haroon A, Wassef C. Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine. Cureus 2022. [DOI: 10.7759/cureus.24126] [Reference Citation Analysis]
140 Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
141 Padniewski JJ, Jacobson‐dunlop E, Albadri S, Hylwa S. Stevens–Johnson syndrome precipitated by Moderna Inc. COVID ‐19 vaccine: a case‐based review of literature comparing vaccine and drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis. Int J Dermatology. [DOI: 10.1111/ijd.16222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Szebeni J, Storm G, Ljubimova JY, Castells M, Phillips EJ, Turjeman K, Barenholz Y, Crommelin DJA, Dobrovolskaia MA. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nat Nanotechnol 2022. [PMID: 35393599 DOI: 10.1038/s41565-022-01071-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
143 García-rueda JE, Caicedo-bolaños AM, Bermúdez-flórez AM, Baena-gallego F, Gómez-ramírez LA, Correa-ángel AL, Vásquez-ochoa LA. Pitiriasis rosada como manifestación dermatológica de infección por SARS-CoV-2: a propósito de un caso. Med Lab 2022;26:177-186. [DOI: 10.36384/01232576.575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Watanabe H, Ashida M, Satomi N, Koike Y, Kuwatsuka S, Murota H. Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell. J Dermatol 2022. [PMID: 35373396 DOI: 10.1111/1346-8138.16374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Marzano AV, Maronese CA, Genovese G, Ferrucci S, Moltrasio C, Asero R, Cugno M. Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis. J Allergy Clin Immunol 2022;149:1137-49. [PMID: 35396080 DOI: 10.1016/j.jaci.2022.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
146 Pour Mohammad A, Mashayekhi F, Seirafianpour F, Gholizadeh Mesgarha M, Goodarzi A. COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Mushtaq HA, Khedr A, Koritala T, Bartlett BN, Jain NK, Khan SA. A review of adverse effects of COVID-19 vaccines. Infez Med 2022;30:1-10. [PMID: 35350266 DOI: 10.53854/liim-3001-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Buranasakda M, Kotruchin P, Phanthachai K, Mootsikapun P, Chetchotisakd P. Varicella zoster meningitis following COVID-19 vaccination: a report of two cases. Int J Infect Dis 2022;119:214-6. [PMID: 35367355 DOI: 10.1016/j.ijid.2022.03.055] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Cazzato G, Romita P, Foti C, Lobreglio D, Trilli I, Colagrande A, Ingravallo G, Resta L. Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation? Vaccines 2022;10:532. [DOI: 10.3390/vaccines10040532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
150 Okazaki T, Matashiro M, Kodama G, Tshubota T, Furusawa Y, Izumi S. Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA Vaccination. Vaccines 2022;10:517. [DOI: 10.3390/vaccines10040517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Grieco T, Ambrosio L, Trovato F, Vitiello M, Demofonte I, Fanto M, Paolino G, Pellacani G. Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study. J Clin Med 2022;11:1822. [PMID: 35407429 DOI: 10.3390/jcm11071822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
152 Arackal NS, Kalaparambath AJ, Kidangeth FK, Nedungattu AB, George S. Covid-19 vaccines pharmacovigilance-a rapid review. Asian Jour Hosp Phar 2022. [DOI: 10.38022/ajhp.v2i1.47] [Reference Citation Analysis]
153 Malcolm TR, Shah YB. Woman with pruritic rash and dermatographism. JACEP Open 2022;3. [DOI: 10.1002/emp2.12709] [Reference Citation Analysis]
154 Petruzzi M, Galleggiante S, Messina S, Della Vella F. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases. BMC Oral Health 2022;22:90. [PMID: 35331228 DOI: 10.1186/s12903-022-02124-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
155 Rabail R, Ahmed W, Ilyas M, Rajoka MSR, Hassoun A, Khalid AR, Khan MR, Aadil RM. The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization. Vaccines (Basel) 2022;10:488. [PMID: 35455237 DOI: 10.3390/vaccines10040488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
156 Bramhoff AC, Wesselmann U, Bender ST, Berghoff AV, Hofmann SC, Balakirski G. [Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?]. Hautarzt 2022. [PMID: 35296923 DOI: 10.1007/s00105-022-04972-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Cavazos A, Deb A, Sharma U, Nugent K. COVID toes following vaccination. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2043732] [Reference Citation Analysis]
158 Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review. Microorganisms 2022;10:624. [DOI: 10.3390/microorganisms10030624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
159 Cau R, Mantini C, Monti L, Mannelli L, Di Dedda E, Mahammedi A, Nicola R, Roubil J, Suri JS, Cerrone G, Fanni D, Faa G, Carriero A, Scuteri A, Francone M, Saba L. Role of imaging in rare COVID-19 vaccine multiorgan complications. Insights Imaging 2022;13. [DOI: 10.1186/s13244-022-01176-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Fenner B, Marquez JL, Pham M, Tarbox M. Inverse pityriasis rosea secondary to COVID-19 vaccination. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2044742] [Reference Citation Analysis]
161 Akyön ŞH, Genç Y. Pityriasis Rosea After Pfizer-BioNTech Covid-19 Vaccine: A Case Report. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1072232] [Reference Citation Analysis]
162 Alshammari F, Alzomia M, Korairi A, Alajlan M, Abuzied Y, Alsheef M. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report. Annals of Medicine and Surgery 2022. [DOI: 10.1016/j.amsu.2022.103420] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
163 El Minawi H, Abdelgawad A, El Saloussy Y, Abdelgawad BA. Postoperative Cutaneous Manifestations as the First Presentation of COVID-19 Infection or a Postvaccination Sequel. Plast Reconstr Surg Glob Open 2022;10:e4163. [PMID: 35223348 DOI: 10.1097/GOX.0000000000004163] [Reference Citation Analysis]
164 Herzum A, Micalizzi C, Molle MF, Parodi A. New‐onset vitiligo following COVID‐19 disease. Skin Health and Disease 2022;2. [DOI: 10.1002/ski2.86] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Hébert M, Couture S, Schmit I. Bilateral Panuveitis with Occlusive Vasculitis following Coronavirus Disease 2019 Vaccination. Ocul Immunol Inflamm 2022;:1-5. [PMID: 35226580 DOI: 10.1080/09273948.2022.2042325] [Reference Citation Analysis]
166 Maronese CA, Caproni M, Moltrasio C, Genovese G, Vezzoli P, Sena P, Previtali G, Cozzani E, Gasparini G, Parodi A, Atzori L, Antiga E, Maglie R, Moro F, Mariotti EB, Corrà A, Pallotta S, Didona B, Marzano AV, Di Zenzo G. Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study. Front Med (Lausanne) 2022;9:841506. [PMID: 35295599 DOI: 10.3389/fmed.2022.841506] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
167 Alrawashdah HM, Al-habahbeh O, Naser AY, Abu Serhan H, Hamdan O, Sweiss K, Aldalameh Y. Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature. Cureus 2022. [DOI: 10.7759/cureus.22669] [Reference Citation Analysis]
168 Gringeri M, Battini V, Cammarata G, Mosini G, Guarnieri G, Leoni C, Pozzi M, Radice S, Clementi E, Carnovale C. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines 2022;:1-10. [PMID: 35191364 DOI: 10.1080/14760584.2022.2044799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
169 Alamri A, Alghamdi Y, Alamri SJ, Althaqafi MK, Alqurashi W, Bader BA, Mohanna AT, Almahdi B. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Cureus 2022. [DOI: 10.7759/cureus.22414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Dézsi L, Mészáros T, Kozma G, H-Velkei M, Oláh CZ, Szabó M, Patkó Z, Fülöp T, Hennies M, Szebeni M, Barta BA, Merkely B, Radovits T, Szebeni J. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor. Geroscience 2022. [PMID: 35146583 DOI: 10.1007/s11357-021-00495-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
171 Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022. [PMID: 35141881 DOI: 10.1111/ijd.16063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
172 Chu CW, Jiesisibieke ZL, Yang YP, Wu PC, Lin HL, Tung TH. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis. Expert Rev Vaccines 2022. [PMID: 35112938 DOI: 10.1080/14760584.2022.2036128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Anzola AM, Trives L, Martínez-Barrio J, Pinilla B, Álvaro-Gracia JM, Molina-Collada J. New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? Clin Rheumatol 2022. [PMID: 35112193 DOI: 10.1007/s10067-021-06041-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
174 Almuhizi F, Ton-leclerc S, Fein M, Tsoukas C, Garvey LH, Lee D, Ben-shoshan M, Isabwe GAC, Copaescu AM. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose. Front Allergy 2022;3:825164. [DOI: 10.3389/falgy.2022.825164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
175 Barbaud A, Garvey LH, Arcolaci A, Brockow K, Mori F, Mayorga C, Bonadonna P, Atanaskovic-Markovic M, Moral L, Zanoni G, Pagani M, Soria A, Jošt M, Caubet JC, Carmo A, Mona AA, Alvarez-Perea A, Bavbek S, Benedetta B, Bilo MB, Blanca-López N, Bogas HG, Buonomo A, Calogiuri G, Carli G, Cernadas J, Cortellini G, Celik G, Demir S, Doña I, Dursun AB, Eberlein B, Faria E, Fernandes B, Garcez T, Garcia-Nunez I, Gawlik R, Gelincik A, Gomes E, Gooi JHC, Grosber M, Gülen T, Hacard F, Hoarau C, Janson C, Johnston SL, Joerg L, Kepil Özdemir S, Klimek L, Košnik M, Kowalski ML, Kuyucu S, Kvedariene V, Laguna JJ, Lombardo C, Marinho S, Merk H, Meucci E, Morisset M, Munoz-Cano R, Murzilli F, Nakonechna A, Popescu FD, Porebski G, Radice A, Regateiro FS, Röckmann H, Romano A, Sargur R, Sastre J, Scherer Hofmeier K, Sedláčková L, Sobotkova M, Terreehorst I, Treudler R, Walusiak-Skorupa J, Wedi B, Wöhrl S, Zidarn M, Zuberbier T, Agache I, Torres MJ. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper. Allergy 2022. [PMID: 35112371 DOI: 10.1111/all.15241] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
176 Pérez-lópez I, Gil-villalba A, Ruiz-villaverde R. Perniosis-like lesions after vaccination with mRNA against COVID-19. Medicina Clínica (English Edition) 2022;158:189-190. [DOI: 10.1016/j.medcle.2021.05.016] [Reference Citation Analysis]
177 Fasano G, Bennardo L, Ruffolo S, Passante M, Ambrosio AG, Napolitano M, Provenzano E, Nisticò SP, Patruno C. Erythema Migrans-like COVID Vaccine Arm: A Literature Review. J Clin Med 2022;11:797. [PMID: 35160249 DOI: 10.3390/jcm11030797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
178 Takeyama R, Fukuda K, Kouzaki Y, Koga T, Hayashi S, Ohtani H, Inoue T. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta Neurochir (Wien) 2022;164:543-7. [PMID: 34783899 DOI: 10.1007/s00701-021-05038-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
179 Naoum C, Hartmann M. Herpes zoster reactivation after COVID‐19 vaccination – a retrospective case series of 22 patients. Int J Dermatology. [DOI: 10.1111/ijd.16116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Goubar T, Star P, Donlon J, Gilbey T, Smith A. Bullous neutrophilic dermatosis with severe acral oedema post‐ COVID ‐19 mRNA vaccination. Aust J Dermatology. [DOI: 10.1111/ajd.13783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Milo RB. Differential Diagnosis of Lesions. Adv Emerg Nurs J 2022;44:23-8. [PMID: 35089277 DOI: 10.1097/TME.0000000000000388] [Reference Citation Analysis]
182 Caffarelli C, Liotti L, Bianchi A, Bottau P, Caimmi S, Crisafulli G, Franceschini F, Paglialunga C, Saretta F, Mori F. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2. Pediatr Allergy Immunol 2022;33 Suppl 27:58-60. [PMID: 35080320 DOI: 10.1111/pai.13631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Parker ER, Fitzpatrick A. A case report of COVID-19-associated erythema nodosum: a classic presentation with a new trigger. Family Practice 2022. [DOI: 10.1093/fampra/cmab177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Metin Z, Celepli P. A case of morphea following the COVID ‐19 mRNA vaccine: on the basis of viral spike proteins. Int J Dermatology. [DOI: 10.1111/ijd.16062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
185 Hatami P, Nicknam Asl H, Aryanian Z. Cutaneous Manifestations of COVID-19 in Children: Practical Points for Clinicians. J Skin Stem Cell 2022;8. [DOI: 10.5812/jssc.122260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
186 Montero-Menárguez J, Falkenhain-López D, Guzmán-Pérez LM, Rodríguez-Peralto JL, Tous-Romero F, Gallego-Álvarez S. Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine. Int J Dermatol 2022. [PMID: 35049059 DOI: 10.1111/ijd.16037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Gisondi P, Bellinato F, Girolomoni G. Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. J Eur Acad Dermatol Venereol 2022;36:165-6. [PMID: 35037307 DOI: 10.1111/jdv.17854] [Reference Citation Analysis]
188 Pudukadan D. Papulopustular rash following Moderna COVID-19 (mRNA-1273) vaccine: A case report. JSSTD 2022;4:110-114. [DOI: 10.25259/jsstd_85_2021] [Reference Citation Analysis]
189 Huang YW, Tsai TF. Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center. Front Med (Lausanne) 2021;8:812010. [PMID: 35004790 DOI: 10.3389/fmed.2021.812010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
190 Žilėnaitė E, Malinauskienė L, Černiauskas K, Griguola L, Linauskienė K, Kvedarienė V, Chomičienė A. Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center. AML 2022;29:1. [DOI: 10.15388/amed.2022.29.1.1] [Reference Citation Analysis]
191 Barry M, AlRajhi A, Aljerian K. Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult. Vaccines (Basel) 2022;10:87. [PMID: 35062748 DOI: 10.3390/vaccines10010087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
192 Mohamed MMB, Wickman TJ, Fogo AB, Velez JCQ. De Novo Immunoglobulin A Vasculitis Following Exposure to SARS-CoV-2 Immunization. Ochsner J 2021;21:395-401. [PMID: 34984055 DOI: 10.31486/toj.21.0083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
193 Boualila L, Mrini B, Tagmouti A, El Moubarik N, Benchekroun Belabbes M, Boutimzine N, Cherkaoui LO. Sinopharm COVID-19 vaccine-induced Stevens-Johnson syndrome. J Fr Ophtalmol 2022:S0181-5512(22)00004-3. [PMID: 35033375 DOI: 10.1016/j.jfo.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Teymour S, Ahram A, Blackwell T, Bhate C, Cohen PJ, Whitworth JM. Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine. Dermatol Ther 2022;:e15302. [PMID: 34984777 DOI: 10.1111/dth.15302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
195 García-Mendoza P, Espinoza-Hernández J, Moreno-Coutiño G. Lichenoid Drug Reaction Post-COVID Vaccination with the Modified Chimpanzee Adenovirus. Indian J Dermatol 2022;67:427-8. [PMID: 36578763 DOI: 10.4103/ijd.ijd_747_21] [Reference Citation Analysis]
196 Triwatcharikorn J, Klaewsongkram J, Rerknimitr P. Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein. Asia Pac Allergy 2022;12:e27. [DOI: 10.5415/apallergy.2022.12.e27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Fernández-Figueras MT. Dermatopathology of COVID-19 infection and vaccination. Pathologie (Heidelb) 2022;43:114-8. [PMID: 36197514 DOI: 10.1007/s00292-022-01126-9] [Reference Citation Analysis]
198 Sil A, Jakhar D, Das A, Jagadeesan S, Aradhya SS. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India. Indian J Dermatol 2022;67:115-20. [PMID: 36092222 DOI: 10.4103/ijd.ijd_893_21] [Reference Citation Analysis]
199 Đorđević Betetto L, Luzar B, Pipan Tkalec Ž, Ponorac S. Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review. Acta Dermatovenerologica Alpina Pannonica et Adriatica 2022;31. [DOI: 10.15570/actaapa.2022.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
200 Pitlick MM, Joshi AY, Gonzalez-Estrada A, Chiarella SE. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination. Allergy Asthma Proc 2022;43:40-3. [PMID: 34983709 DOI: 10.2500/aap.2022.43.210101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
201 Alsharif F, Alotaibi S, Alharithy R, Alkhayal N. Lichen planus after COVID-19 vaccination: A report of two cases. J Dermatol Dermatol Surg 2022;26:57. [DOI: 10.4103/jdds.jdds_15_22] [Reference Citation Analysis]
202 Brooks SG, De Jong AM, Abbaslou M, Sussman G. Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report. Allergy Rhinol (Providence) 2022;13:21526567211068458. [PMID: 35036040 DOI: 10.1177/21526567211068458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
203 Yoon W, Park Y, Kim S, Bang IS. Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2. Vaccines (Basel) 2022;10:67. [PMID: 35062728 DOI: 10.3390/vaccines10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
204 Bhargava A, Kharkar V, Mahajan S, Gole P. Neutrophilic pustular eruption with behcet's like illness post Covid-19 vaccination. Indian Dermatol Online J 2022;13:493. [DOI: 10.4103/idoj.idoj_29_22] [Reference Citation Analysis]
205 Kim DH, Cho JH, Park SJ, Seo SH, Ahn HH. Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea. J Korean Med Sci 2022;37:e190. [DOI: 10.3346/jkms.2022.37.e190] [Reference Citation Analysis]
206 Žilėnaitė E, Malinauskienė L, Černiauskas K, Griguola L, Linauskienė K, Kvedarienė V, Chomičienė A. Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center. Acta Med Litu 2022;29:27-32. [PMID: 36061933 DOI: 10.15388/Amed.2021.29.1.1] [Reference Citation Analysis]
207 Alnaim A, Al-mulhim A, Al-momen M, Shaikh L. Saudi adolescent present with new-onset vitiligo post-COVID-19 vaccination: Case report. J Dermatol Dermatol Surg 2022;26:96. [DOI: 10.4103/jdds.jdds_35_22] [Reference Citation Analysis]
208 Jaspreet D, Vivian W, Ziwei W, Brittney P, Jamie Y, Yusin J. Vaccination. Absolute Allergy and Immunology Board Review 2022. [DOI: 10.1007/978-3-031-12867-7_30] [Reference Citation Analysis]
209 Patil S, Narwade G. COVID-19 vaccine-related immunological adverse event presented as reversible autoimmune disease with rheumatological feature and pulmonary infiltrates. J Adv Lung Health 2022;2:105. [DOI: 10.4103/jalh.jalh_5_22] [Reference Citation Analysis]
210 Abdulla M. Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine. Indian J Med Spec 2022;13:263. [DOI: 10.4103/injms.injms_87_22] [Reference Citation Analysis]
211 Pelchat F, Fournier C, Perron E, Gilbert M, Delisle B. Sweet syndrome following Moderna COVID-19 vaccine: A case report. SAGE Open Medical Case Reports 2022;10:2050313X2211178. [DOI: 10.1177/2050313x221117884] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Yentzer B, Clark B. Delayed-onset urticaria following vaccination for COVID-19. J Dermatol Dermatol Surg 2022;26:70. [DOI: 10.4103/jdds.jdds_67_22] [Reference Citation Analysis]
213 Altun E, Kuzucular E. Leukocytoclastic vasculitis after COVID ‐19 vaccination. Dermatologic Therapy. [DOI: 10.1111/dth.15279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
214 Kothari RS, Subramani D, Asnani DR, Raman A, Deora MS, Gupta A. Erythema multiforme after Covishield/ChAdOx1 vaccination. Dermatol Ther 2021;:e15289. [PMID: 34962029 DOI: 10.1111/dth.15289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Nazzaro G, Maronese CA. Urticarial vasculitis following mRNA anti-COVID-19 vaccine. Dermatol Ther 2021;:e15282. [PMID: 34931406 DOI: 10.1111/dth.15282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
216 Massip E, Marcant P, Font G, Faiz S, Duvert-Lehembre S, Alcaraz I, Vermersch-Langlin A, Véron M, Macaire C, Faure K, Vuotto F, Staumont-Sallé D, Dezoteux F. Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort. J Eur Acad Dermatol Venereol 2021. [PMID: 34927749 DOI: 10.1111/jdv.17883] [Reference Citation Analysis]
217 Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, Fontana L, Salvarani C, Cimino L. Uveitis and Other Ocular Complications Following COVID-19 Vaccination. J Clin Med 2021;10:5960. [PMID: 34945256 DOI: 10.3390/jcm10245960] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
218 Koç Yıldırım S. A new-onset vitiligo following the inactivated COVID-19 vaccine. J Cosmet Dermatol 2021. [PMID: 34910371 DOI: 10.1111/jocd.14677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
219 Rosi E, Fastame MT, Di Cesare A, Silvi G, Pimpinelli N, Prignano F. Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. J Clin Med 2021;10:5841. [PMID: 34945136 DOI: 10.3390/jcm10245841] [Reference Citation Analysis]
220 Knechtl GV, Seyed Jafari SM, Berger T, Rammlmair A, Feldmeyer L, Borradori L. Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient. J Eur Acad Dermatol Venereol 2021. [PMID: 34897817 DOI: 10.1111/jdv.17868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
221 Camela E, Guerrasio G, Patruno C, Scalvenzi M, Di Caprio N, Fabbrocini G, Napolitano M. Reply to 'New-onset cutaneous lichen planus triggered by COVID-19 vaccination' by Merhy et al. J Eur Acad Dermatol Venereol 2021. [PMID: 34902185 DOI: 10.1111/jdv.17866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
222 Rosińska-Więckowicz A, Jałowska M, Bowszyc-Dmochowska M, Dmochowski M. Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative. Front Med (Lausanne) 2021;8:760823. [PMID: 34881262 DOI: 10.3389/fmed.2021.760823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Popatia S, Chiu YE. Vulvar aphthous ulcer after COVID-19 vaccination. Pediatr Dermatol 2021. [PMID: 34888935 DOI: 10.1111/pde.14881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
224 Wei N, Kresch M, Elbogen E, Lebwohl M. New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Rep 2022;19:74-7. [PMID: 34869811 DOI: 10.1016/j.jdcr.2021.11.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
225 Shahrigharahkoshan S, Gagnon LP, Mathieu S. Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus 2021;13:e19005. [PMID: 34853744 DOI: 10.7759/cureus.19005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Doughty H, Barton D. Severe nonanaphylactic allergic reaction to the Pfizer-BioNTech COVID-19 vaccine. JAAD Case Rep 2022;19:84-6. [PMID: 34849387 DOI: 10.1016/j.jdcr.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Kano Y, Kasami S, Murata K, Kato M. Erythema multiforme after SARS-CoV-2 messenger RNA vaccination. QJM 2021:hcab303. [PMID: 34865149 DOI: 10.1093/qjmed/hcab303] [Reference Citation Analysis]
228 Arkin LM, Moon JJ, Tran JM, Asgari S, O'Farrelly C, Casanova JL, Cowen EW, Mays JW, Singh AM, Drolet BA; COVID Human Genetic Effort. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. J Invest Dermatol 2021;141:2791-6. [PMID: 34561087 DOI: 10.1016/j.jid.2021.05.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
229 Lewitt T, Chung C, Manton J, Sergeyenko A, Tan T, Sigal A, Zhou X(, Guitart J. Rare lymphomatoid reactions following SARS-CoV-2 vaccination. JAAD Case Reports 2021. [DOI: 10.1016/j.jdcr.2021.11.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
230 Risma KA. COVID-19 mRNA vaccine allergy. Curr Opin Pediatr 2021;33:610-7. [PMID: 34670264 DOI: 10.1097/MOP.0000000000001077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
231 Senet P. Quoi de neuf en dermatologie clinique ? Annales de Dermatologie et de Vénéréologie - FMC 2021;1:8S1-8S11. [DOI: 10.1016/s2667-0623(21)01524-5] [Reference Citation Analysis]
232 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
233 Burlando M, Herzum A, Micalizzi C, Cozzani E, Parodi A. Cutaneous reactions to COVID-19 vaccine at the dermatology primary care. Immun Inflamm Dis 2022;10:265-71. [PMID: 34837354 DOI: 10.1002/iid3.568] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
234 Chapin-Bardales J, Myers T, Gee J, Shay DK, Marquez P, Baggs J, Zhang B, Licata C, Shimabukuro TT. Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system. Vaccine 2021;39:7066-73. [PMID: 34763946 DOI: 10.1016/j.vaccine.2021.10.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
235 Sellaturay P, Gurugama P, Harper V, Dymond T, Ewan P, Nasser S. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients. Clin Exp Allergy 2022;52:12-7. [PMID: 34822190 DOI: 10.1111/cea.14064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
236 Mansouri P, Chalangari R, Martits-Chalangari K, Mozafari N. Stevens-Johnson Syndrome due to COVID-19 vaccination. Clin Case Rep 2021;9:e05099. [PMID: 34815881 DOI: 10.1002/ccr3.5099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
237 Iwasawa O, Kamiya K, Okada H, Komine M, Ohtsuki M. A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination. J Dermatol 2021. [PMID: 34821411 DOI: 10.1111/1346-8138.16257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Iwasawa O, Kamiya K, Komine M, Ohtsuki M. Case of atypical erythema multiforme following coronavirus disease 2019 vaccination. J Dermatol 2021. [PMID: 34821413 DOI: 10.1111/1346-8138.16255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
239 Pourani MR, Shahidi Dadras M, Salari M, Diab R, Namazi N, Abdollahimajd F. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients. Dermatol Ther 2021;:e15223. [PMID: 34820975 DOI: 10.1111/dth.15223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
240 Gronbeck C, Grant-Kels JM. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them! Clin Dermatol 2021;39:674-87. [PMID: 34809772 DOI: 10.1016/j.clindermatol.2021.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
241 Birabaharan M, Kaelber DC, Karris MY. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study. J Am Acad Dermatol 2021:S0190-9622(21)02892-9. [PMID: 34826538 DOI: 10.1016/j.jaad.2021.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
242 Brockow K, Mathes S, Fischer J, Volc S, Darsow U, Eberlein B, Biedermann T. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis. Allergy 2021. [PMID: 34806775 DOI: 10.1111/all.15183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
243 Stoyanov A, Thompson G, Lee M, Katelaris C. Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash. Ann Allergy Asthma Immunol 2021:S1081-1206(21)01274-6. [PMID: 34813953 DOI: 10.1016/j.anai.2021.11.014] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
244 Rauso R, Lo Giudice G, Zerbinati N, Nicoletti GF, Fragola R, Tartaro G. Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report. Applied Sciences 2021;11:10888. [DOI: 10.3390/app112210888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 Poulas K, Farsalinos K. Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases". J Am Acad Dermatol 2021:S0190-9622(21)02840-1. [PMID: 34801633 DOI: 10.1016/j.jaad.2021.09.071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Freeman EE, Sun Q, McMahon DE, Singh R, Fathy R, Tyagi A, Blumenthal K, Hruza GJ, French LE, Fox LP. Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type. J Am Acad Dermatol 2021:S0190-9622(21)02841-3. [PMID: 34800601 DOI: 10.1016/j.jaad.2021.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
247 Henry D, Henry D. Herpes zoster following ChAdOx1 nCoV-19 corona virus vaccine (recombinant): A case report. JSSTD 2021;4:136-138. [DOI: 10.25259/jsstd_73_2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
248 Temiz SA, Abdelmaksoud A, Wollina U, Kutlu O, Dursun R, Patil A, Lotti T, Goldust M, Vestita M. Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review. J Cosmet Dermatol 2021. [PMID: 34791757 DOI: 10.1111/jocd.14613] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
249 Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. J Clin Med 2021;10:5344. [PMID: 34830627 DOI: 10.3390/jcm10225344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
250 Pitlick MM, Sitek AN, D'Netto ME, Dages KN, Chiarella SE, Gonzalez-Estrada A, Joshi AY, Park MA. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions. Ann Allergy Asthma Immunol 2021:S1081-1206(21)01252-7. [PMID: 34798275 DOI: 10.1016/j.anai.2021.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
251 Heidari S, Palmer-Ross A, Goodman T. A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials. Vaccines (Basel) 2021;9:1322. [PMID: 34835253 DOI: 10.3390/vaccines9111322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
252 Grossman ME, Appel G, Little AJ, Ko CJ. Post-COVID-19 vaccination IgA vasculitis in an adult. J Cutan Pathol 2021. [PMID: 34779011 DOI: 10.1111/cup.14168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
253 Picone V, Martora F, Fabbrocini G, Marano L. "Covid arm": Abnormal side effect after Moderna COVID-19 vaccine. Dermatol Ther 2021;:e15197. [PMID: 34750923 DOI: 10.1111/dth.15197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
254 Cinotti E, Perrot JL, Bruzziches F, Tognetti L, Batsikosta A, Sorrentino E, Marzano AV, Rubegni P. Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34753210 DOI: 10.1111/jdv.17806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Sernicola A, Dybala A, Gomes V, Maddalena P, Adotti F, Soda G, Muharremi R, Fino P, Del Duca E, Grieco T. Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption. J Eur Acad Dermatol Venereol 2021. [PMID: 34751995 DOI: 10.1111/jdv.17807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
256 Ciccarese G, Drago F, Boldrin S, Pattaro M, Parodi A. Sudden onset of vitiligo after COVID-19 vaccine. Dermatol Ther 2021;:e15196. [PMID: 34751491 DOI: 10.1111/dth.15196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
257 Balogun M, Millette D, Yip V, Chan SA, Lee P, Gamal N, Hashim N, Phillips D, Walsh M, Trehan P, Hanna-Bashara L, Abdullah A, Wernham A, Tso S. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review. Clin Exp Dermatol 2021. [PMID: 34748655 DOI: 10.1111/ced.15003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 2022;43:3-40. [PMID: 34719776 DOI: 10.1007/s10072-021-05662-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 23.5] [Reference Citation Analysis]
259 Guénin SH, Kresch M, Elbogen E, Lebwohl MG. Cutaneous reaction reported after third Moderna COVID-19 vaccine. JAAD Case Rep 2021;18:49-50. [PMID: 34722839 DOI: 10.1016/j.jdcr.2021.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
260 Shin SH, Hong JK, Hong SA, Li K, Yoo KH. Pityriasis rosea shortly after mRNA-1273 COVID-19 vaccination. Int J Infect Dis 2021:S1201-9712(21)00844-4. [PMID: 34740803 DOI: 10.1016/j.ijid.2021.10.055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
261 Desai HD, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z, Grabbe S, Goldust M. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review. J Cosmet Dermatol 2021;20:3350-61. [PMID: 34719084 DOI: 10.1111/jocd.14521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
262 Magro C, Crowson AN, Franks L, Schaffer PR, Whelan P, Nuovo G. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clinics in Dermatology 2021;39:966-84. [DOI: 10.1016/j.clindermatol.2021.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
263 Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clinics in Dermatology 2021;39:934-65. [DOI: 10.1016/j.clindermatol.2021.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
264 Jordens Q, De Maeseneer H, De Crem C, Fölster-Holst R, Van Gysel D. Acral manifestations associated with infection. Pediatr Dermatol 2021. [PMID: 34713504 DOI: 10.1111/pde.14831] [Reference Citation Analysis]
265 Osmond A, Kenny B. Reaction to dermal filler following COVID-19 vaccination. J Cosmet Dermatol 2021. [PMID: 34706150 DOI: 10.1111/jocd.14566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
266 Bostan E, Zaid F, Akdogan N, Gokoz O. Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis. J Cosmet Dermatol 2021. [PMID: 34705320 DOI: 10.1111/jocd.14568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
267 Thomas J, Thomas G, Chatim A, Shukla P, Mardiney M. Chronic Spontaneous Urticaria After COVID-19 Vaccine. Cureus 2021;13:e18102. [PMID: 34692313 DOI: 10.7759/cureus.18102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
268 Niebel D, Wilhelmi J, De Vos L, Ziob J, Jaschke K, Bieber T, Wenzel J, Braegelmann C. Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon? J Dermatol 2022;49:151-6. [PMID: 34693548 DOI: 10.1111/1346-8138.16210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
269 Watts MM, Maurer LE, Grammer LC, Saltoun CA, Stevens WW. Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine. Ann Allergy Asthma Immunol 2021:S1081-1206(21)01173-X. [PMID: 34699970 DOI: 10.1016/j.anai.2021.10.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
270 Myrdal CN, Culpepper KS, Leyo DuPont S. Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination. Dermatol Ther 2021;34:e15173. [PMID: 34676639 DOI: 10.1111/dth.15173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
271 Li X, Gao L, Tong X, Chan VK, Chui CS, Lai FT, Wong CK, Wan EY, Chan EW, Lau KK, Lau CS, Wong IC. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong.. [DOI: 10.1101/2021.10.21.21265314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Wunderlich K, Dirschka T. [Erythema multiforme following COVID-19 vaccination (BNT162b2)]. Hautarzt 2021. [PMID: 34676438 DOI: 10.1007/s00105-021-04911-4] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
273 Saibene AM, Alliata A, Cozzi AT, Ottavi A, Spagnolini S, Pipolo C, Maccari A, Felisati G. Erythema Multiforme Major following SARS-CoV-2 vaccine. Clin Case Rep 2021;9:e04947. [PMID: 34667612 DOI: 10.1002/ccr3.4947] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
274 Baffa ME, Maglie R, Giovannozzi N, Montefusco F, Senatore S, Massi D, Antiga E. Sweet Syndrome Following SARS-CoV2 Vaccination. Vaccines (Basel) 2021;9:1212. [PMID: 34835143 DOI: 10.3390/vaccines9111212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
275 Bencharattanaphakhi R, Rerknimitr P. Sinovac COVID-19 vaccine-induced cutaneous leukocytoclastic vasculitis. JAAD Case Rep 2021;18:1-3. [PMID: 34660867 DOI: 10.1016/j.jdcr.2021.10.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
276 Lee SW, Lee H, Lee SK, Moon JY, Moon S, Chung SJ, Yeo Y, Park TS, Won Park D, Kim TH, Sohn JW, Yoon HJ, Kim SH. Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2. Front Med (Lausanne) 2021;8:738049. [PMID: 34660644 DOI: 10.3389/fmed.2021.738049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
277 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 26.5] [Reference Citation Analysis]
278 Rerknimitr P, Puaratanaarunkon T, Wongtada C, Wittayabusarakam N, Krithin S, Paitoonpong L, Kumtornrut C, Kerr SJ, Asawanonda P, Jantarabenjakul W, Klaewsongkram J. Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers. J Eur Acad Dermatol Venereol 2021. [PMID: 34661934 DOI: 10.1111/jdv.17761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
279 Kim MJ, Kim JW, Kim MS, Choi SY, Na JI. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech). J Eur Acad Dermatol Venereol 2021. [PMID: 34661942 DOI: 10.1111/jdv.17757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
280 Kouki C, Sellami K, Bahloul E, Amouri M, Masmoudi A, Turki H. Response to 'A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine'. J Eur Acad Dermatol Venereol 2021. [PMID: 34657348 DOI: 10.1111/jdv.17751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Hibino M, Ishihara T, Iwata M, Doi Y. Delayed Injection Site Reaction After mRNA-1273 Vaccination in Japan: A Retrospective, Cross-Sectional Study. Open Forum Infect Dis 2021;8:ofab497. [PMID: 34651054 DOI: 10.1093/ofid/ofab497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
282 Alhumaid S, Al Mutair A, Al Alawi Z, Rabaan AA, Tirupathi R, Alomari MA, Alshakhes AS, Alshawi AM, Ahmed GY, Almusabeh HM, Alghareeb TT, Alghuwainem AA, Alsulaiman ZA, Alabdulmuhsin MA, AlBuwaidi EA, Dukhi AKB, Mufti HN, Al-Qahtani M, Dhama K, Al-Tawfiq JA, Al-Omari A. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis. Allergy Asthma Clin Immunol 2021;17:109. [PMID: 34656181 DOI: 10.1186/s13223-021-00613-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
283 Onn PY, Chang CL. Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration. Respirol Case Rep 2021;9:e0860. [PMID: 34631106 DOI: 10.1002/rcr2.860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
284 Ho TC, Chen YA, Chan HP, Chang CC, Chuang KP, Lee CH, Yuan CH, Tyan YC, Yang MH. The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2. Vaccines (Basel) 2021;9:1163. [PMID: 34696271 DOI: 10.3390/vaccines9101163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
285 Grieco T, Maddalena P, Sernicola A, Muharremi R, Basili S, Alvaro D, Cangemi R, Rossi A, Pellacani G. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study. Dermatol Ther 2021;34:e15153. [PMID: 34622531 DOI: 10.1111/dth.15153] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
286 Sechi A, Pierobon E, Pezzolo E, Germi L, Trevisan G, Zardo D, Riva G, Mondino S, Naldi L. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine. Clin Exp Dermatol 2021. [PMID: 34617317 DOI: 10.1111/ced.14970] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
287 Ricardo JW, Lipner SR. Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. JAAD Case Rep 2021;17:18-20. [PMID: 34611542 DOI: 10.1016/j.jdcr.2021.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
288 Koumaki D, Krueger-Krasagakis SE, Papadakis M, Katoulis A, Koumaki V, Evangelou G, Stefanidou M, Mylonakis D, Zografaki K, Krasagakis K. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. J Eur Acad Dermatol Venereol 2021. [PMID: 34606142 DOI: 10.1111/jdv.17720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
289 Brooks SG, Alhusayen R, Piguet V, Croitoru D. Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence. J Eur Acad Dermatol Venereol 2021. [PMID: 34606671 DOI: 10.1111/jdv.17719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
290 Poizeau F, Oger E, Barbarot S, Le Corre Y, Samimi M, Brenaut E, Aubert H, Chambrelan E, Droitcourt C, Gissot V, Heslan C, Laurent C, Martin L, Misery L, Tattevin P, Toubel A, Thibault V, Dupuy A. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study. Clin Microbiol Infect 2021:S1198-743X(21)00561-9. [PMID: 34619397 DOI: 10.1016/j.cmi.2021.09.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
291 Kluger N, Klimenko T, Bosonnet S. Herpes simplex, herpes zoster and periorbital erythema flares after SARS-CoV-2 vaccination: 4 cases. Ann Dermatol Venereol 2021:S0151-9638(21)00092-2. [PMID: 34711399 DOI: 10.1016/j.annder.2021.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
292 Nishi J. Effectiveness and Safety of COVID-19 Vaccine. tits 2021;26:10_18-10_25. [DOI: 10.5363/tits.26.10_18] [Reference Citation Analysis]
293 Li L, Robinson LB, Patel R, Landman AB, Fu X, Shenoy ES, Hashimoto DM, Banerji A, Wickner PG, Samarakoon U, Mancini CM, Zhang Y, Blumenthal KG. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA Netw Open 2021;4:e2131034. [PMID: 34698847 DOI: 10.1001/jamanetworkopen.2021.31034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
294 Said JT, Virgen CA, Lian CG, Cutler CS, Merola JF, LeBoeuf NR. Disseminated varicella-zoster virus infections following messenger RNA-based COVID-19 vaccination. JAAD Case Rep 2021;17:126-9. [PMID: 34568532 DOI: 10.1016/j.jdcr.2021.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
295 Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology (Basel) 2021;8:463-76. [PMID: 34698094 DOI: 10.3390/dermatopathology8040049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
296 Leerunyakul K, Pakornphadungsit K, Suchonwanit P. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Front Med (Lausanne) 2021;8:752443. [PMID: 34557507 DOI: 10.3389/fmed.2021.752443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
297 Freeman EE, Chamberlin GC, McMahon DE, Hruza GJ, Wall D, Meah N, Sinclair R, Balogh EA, Feldman SR, Lowes MA, Marzano AV, Naik HB, Castelo-Soccio L, Lara-Corrales I, Cordoro KM, Mahil SK, Griffiths CEM, Smith CH, Irvine AD, Spuls PI, Flohr C, French LE. Dermatology COVID-19 Registries: Updates and Future Directions. Dermatol Clin 2021;39:575-85. [PMID: 34556247 DOI: 10.1016/j.det.2021.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
298 Freeman EE, McMahon DE. COVID-19 and Dermatology: One Year in Review. Dermatol Clin 2021;39:xv-xvi. [PMID: 34556255 DOI: 10.1016/j.det.2021.06.001] [Reference Citation Analysis]
299 Iwanaga J, Fukuoka H, Fukuoka N, Yutori H, Ibaragi S, Tubbs RS. A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination. Clin Anat 2021. [PMID: 34554601 DOI: 10.1002/ca.23790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
300 Vaccaro M, Bertino L, Squeri R, Genovese C, Isola S, Spatari G, Spina E, Cutroneo P. Early atypical injection‐site reactions to COVID‐19 vaccine: a case series. J Eur Acad Dermatol Venereol 2022;36. [DOI: 10.1111/jdv.17683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
301 Aoki N, Saruta Y, Tanaka S, Nakajima R, Sano H, Sano S. Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine. J Dermatol 2021;48:e596-7. [PMID: 34545609 DOI: 10.1111/1346-8138.16163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
302 Young J, Mercieca L, Ceci M, Pisani D, Betts A, Boffa MJ. A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34547137 DOI: 10.1111/jdv.17676] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
303 Sandhu S, Bhatnagar A, Kumar H, Dixit PK, Paliwal G, Suhag DK, Patil C, Mitra D. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant). Dermatol Ther 2021;:e15141. [PMID: 34546608 DOI: 10.1111/dth.15141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
304 Mehta H, Handa S, Malhotra P, Patial M, Gupta S, Mukherjee A, Chatterjee D, Takkar A, Mahajan R. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India. J Eur Acad Dermatol Venereol 2021. [PMID: 34547126 DOI: 10.1111/jdv.17678] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
305 Borg L, Mercieca L, Mintoff D, Micallef D, Pisani D, Betts A, Scerri L. Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme. J Eur Acad Dermatol Venereol 2021. [PMID: 34547125 DOI: 10.1111/jdv.17682] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
306 Pesqué D, Lopez-Trujillo E, Marcantonio O, Giménez-Arnau AM, Pujol RM. New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? J Eur Acad Dermatol Venereol 2021. [PMID: 34547146 DOI: 10.1111/jdv.17690] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
307 Pedrazini MC, da Silva MH. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review. Dermatol Ther 2021;34:e15129. [PMID: 34533265 DOI: 10.1111/dth.15129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
308 Herbort CP Jr, Papasavvas I. Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients. J Ophthalmic Inflamm Infect 2021;11:33. [PMID: 34533628 DOI: 10.1186/s12348-021-00262-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
309 Kar BR, Singh BS, Mohapatra L, Agrawal I. Cutaneous small-vessel vasculitis following COVID-19 vaccine. J Cosmet Dermatol 2021;20:3382-3. [PMID: 34529877 DOI: 10.1111/jocd.14452] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
310 Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep 2021;17:1-3. [PMID: 34522741 DOI: 10.1016/j.jdcr.2021.08.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
311 Irvine NJ, Wiles BL. Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus 2021;13:e16858. [PMID: 34513435 DOI: 10.7759/cureus.16858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
312 Cugno M, Consonni D, Lombardi A, Bono P, Oggioni M, Uceda Renteria S, Pesatori AC, Castaldi S, Riboldi L, Bordini L, Nava CD, Ceriotti F, Torri A, Tafuri F, Ghigliazza G, Peyvandi F, Bandera A, Gori A. Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors. Vaccines (Basel) 2021;9:1011. [PMID: 34579248 DOI: 10.3390/vaccines9091011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
313 McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol 2021:S0190-9622(21)02442-7. [PMID: 34517079 DOI: 10.1016/j.jaad.2021.09.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 22.0] [Reference Citation Analysis]
314 Huang L, Yao Z, Zhang J. Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine. J Eur Acad Dermatol Venereol 2022;36:e9-e11. [PMID: 34492136 DOI: 10.1111/jdv.17648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
315 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021;112:828-36. [PMID: 34483343 DOI: 10.1016/j.adengl.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Fang WC, Chiu LW, Hu SC. Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine. J Dermatol 2021;48:e566-7. [PMID: 34487570 DOI: 10.1111/1346-8138.16137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
317 Wong CY, Rios EJ. Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine. JAAD Case Rep 2021;16:44-6. [PMID: 34485657 DOI: 10.1016/j.jdcr.2021.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
318 Drohan A, Kolansky G, Kolansky Z. Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine. JAAD Case Rep 2021;16:26-7. [PMID: 34485656 DOI: 10.1016/j.jdcr.2021.07.040] [Reference Citation Analysis]
319 Fathy RA, McMahon DE, Lee C, Chamberlin GC, Rosenbach M, Lipoff JB, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Fassett M, Fox LP, Greenberg HL, Blumenthal K, Freeman EE. Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry. J Eur Acad Dermatol Venereol 2021. [PMID: 34487581 DOI: 10.1111/jdv.17646] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
320 Choi E, Liew CF, Oon HH. Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian country. Dermatol Ther 2021;34:e15123. [PMID: 34478204 DOI: 10.1111/dth.15123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Agaronov A, Makdesi C, Hall CS. Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine. JAAD Case Rep 2021;16:96-7. [PMID: 34466640 DOI: 10.1016/j.jdcr.2021.08.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
322 Nur geringfügige Hautreaktionen nach COVID-19-Impfung beobachtbar. Aktuelle Dermatologie 2021;47:360-362. [DOI: 10.1055/a-1541-3267] [Reference Citation Analysis]
323 Sato T. Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccines. J Dermatol 2021;48:e558-9. [PMID: 34459023 DOI: 10.1111/1346-8138.16123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
324 Tihy M, Menzinger S, André R, Laffitte E, Toutous-Trellu L, Kaya G. Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines. J Eur Acad Dermatol Venereol 2021;35:2456-61. [PMID: 34459036 DOI: 10.1111/jdv.17633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
325 Peigottu MF, Ferreli C, Atzori MG, Atzori L. Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series. Diseases 2021;9:58. [PMID: 34562965 DOI: 10.3390/diseases9030058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
326 Lim RK, Kalagara S, Chen KK, Mylonakis E, Kroumpouzos G. DERMATOLOGY IN A MULTIDISCIPLINARY APPROACH WITH INFECTIOUS DISEASE AND OBSTETRIC MEDICINE AGAINST COVID-19. Int J Womens Dermatol 2021. [PMID: 34462725 DOI: 10.1016/j.ijwd.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
327 Vinay K, Rudramurthy SM, Dogra S. Emergence of Mucormycosis during COVID-19 Pandemic and Dermatological Manifestations. Indian Dermatol Online J 2021;12:493-6. [PMID: 34430451 DOI: 10.4103/idoj.idoj_406_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel) 2021;9:944. [PMID: 34579181 DOI: 10.3390/vaccines9090944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
329 Belina ME, Sarver MM, Al-Rohil R, Fresco A. Lichen striatus post-COVID-19 vaccination. JAAD Case Rep 2021;16:16-8. [PMID: 34423105 DOI: 10.1016/j.jdcr.2021.07.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
330 Holmes GA, Desai M, Limone B, Love J, Tawfik M, Wong L, Furukawa B. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Rep 2021;16:53-7. [PMID: 34423106 DOI: 10.1016/j.jdcr.2021.07.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
331 Wollina U, Chiriac A, Kocic H, Koch A, Brzezinski P. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review. Wien Med Wochenschr 2021. [PMID: 34424434 DOI: 10.1007/s10354-021-00876-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
332 Gregoriou S, Kleidona IA, Tsimpidakis A, Nicolaidou E, Stratigos A, Rigopoulos D. 'COVID vaccine arm' may present after both mRNA vaccines vaccination. J Eur Acad Dermatol Venereol 2021;35:e867-8. [PMID: 34416053 DOI: 10.1111/jdv.17614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
333 Heck E, Rankin BD, Schneider M, Prajapati VH. Flagellate purpura associated with COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34416052 DOI: 10.1111/jdv.17609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
334 Matsubara A, Sakurai M, Morita A. Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination. J Cutan Immunol Allergy 2021;4:187-8. [DOI: 10.1002/cia2.12199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
335 Lim PN, Wylie G. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination. Clin Exp Dermatol 2022;47:175-6. [PMID: 34399001 DOI: 10.1111/ced.14898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
336 Wollina U, Kanitakis J, Baran R. Nails and COVID-19 - A comprehensive review of clinical findings and treatment. Dermatol Ther 2021;:e15100. [PMID: 34398500 DOI: 10.1111/dth.15100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
337 Elamin S, Hinds F, Tolland J. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine. Clin Exp Dermatol 2021. [PMID: 34398977 DOI: 10.1111/ced.14895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
338 Juay L, Chandran NS. Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine). J Eur Acad Dermatol Venereol 2021;35:e855-7. [PMID: 34363258 DOI: 10.1111/jdv.17581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
339 Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther 2021;:e15093. [PMID: 34369046 DOI: 10.1111/dth.15093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
340 Yu JN, Angeles CB, Lim HG, Chavez C, Roxas-Rosete C. Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines. J Eur Acad Dermatol Venereol 2021. [PMID: 34363713 DOI: 10.1111/jdv.17575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
341 Annabi E, Dupin N, Sohier P, Garel B, Franck N, Aractingi S, Guégan S, Oulès B. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. J Eur Acad Dermatol Venereol 2021. [PMID: 34363637 DOI: 10.1111/jdv.17578] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
342 Mohamed Bulla HA. COVID -19: EFFICACY AND SAFETY PROFILE OF MAIN VACCINES APPROVED FOR EMERGENCY USE AUTHORIZATION IN 2021. Int J Res Granthaalayah 2021;9:271-283. [DOI: 10.29121/granthaalayah.v9.i7.2021.4062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
343 Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology (Basel) 2021;10:752. [PMID: 34439984 DOI: 10.3390/biology10080752] [Cited by in Crossref: 70] [Cited by in F6Publishing: 81] [Article Influence: 35.0] [Reference Citation Analysis]
344 Sprute R, Schumacher S, Pauls M, Pauls W, Cornely OA. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2. Drugs R D 2021. [PMID: 34351606 DOI: 10.1007/s40268-021-00358-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
345 Lladó I, Fernández-Bernáldez A, Rodríguez-Jiménez P. Varicella zoster virus reactivation and mRNA vaccines as a trigger. JAAD Case Rep 2021;15:62-3. [PMID: 34316507 DOI: 10.1016/j.jdcr.2021.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
346 Yu X, Li L, Chan MTV, Wu WKK. Bioinformatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster. Environ Sci Pollut Res Int 2021. [PMID: 34322810 DOI: 10.1007/s11356-021-15567-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
347 Merrill ED, Kashem SW, Amerson EH, Pincus LB, Lang UE, Shinkai K, Chang AY. Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine. JAMA Dermatol 2021. [PMID: 34319363 DOI: 10.1001/jamadermatol.2021.2474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
348 Smola A, Samadzadeh S, Müller L, Adams O, Homey B, Albrecht P, Meller S. Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021;35:e743-5. [PMID: 34310766 DOI: 10.1111/jdv.17549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
349 Pasternack R, Pohjavaara S. A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34310755 DOI: 10.1111/jdv.17543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
350 Revilla-Nebreda D, Roncero-Riesco M, Santos-Briz Á, Medina-Migueláñez M, Segurado-Tostón N, Román-Curto C. New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases. J Eur Acad Dermatol Venereol 2021. [PMID: 34310777 DOI: 10.1111/jdv.17553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
351 Guzmán-Pérez L, Puerta-Peña M, Falkenhain-López D, Montero-Menárguez J, Gutiérrez-Collar C, Rodríguez-Peralto JL, Sanz-Bueno J. Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2. J Eur Acad Dermatol Venereol 2021. [PMID: 34310763 DOI: 10.1111/jdv.17547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
352 Lladó I, Butrón B, Sampedro-Ruiz R, Fraga J, de Argila D. Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34310778 DOI: 10.1111/jdv.17542] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
353 Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2021. [PMID: 34292611 DOI: 10.1111/cup.14104] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
354 Channa L, Torre K, Rothe M. Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination. JAAD Case Rep 2021;15:60-1. [PMID: 34316506 DOI: 10.1016/j.jdcr.2021.05.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
355 Papadimitriou I, Bakirtzi K, Sotiriou E, Vakirlis E, Hatzibougias D, Ioannides D. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study. Clin Exp Dermatol 2021. [PMID: 34288056 DOI: 10.1111/ced.14856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
356 Tomayko MM, Damsky W, Fathy R, McMahon DE, Turner N, Valentin MN, Rallis T, Aivaz O, Fox LP, Freeman EE. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol 2021;148:750-1. [PMID: 34275656 DOI: 10.1016/j.jaci.2021.06.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
357 Hussain K, Kawsar A, Weir J, Au L, Turajlic S, Larkin J, Fearfield L. Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit? Clin Exp Dermatol 2021. [PMID: 34260095 DOI: 10.1111/ced.14852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
358 Novak N, Tordesillas L, Cabanillas B. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol 2021;:1-10. [PMID: 34251972 DOI: 10.1080/08830185.2021.1939696] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
359 Kempf W, Kettelhack N, Kind F, Courvoisier S, Galambos J, Pfaltz K. 'COVID arm' - histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine. J Eur Acad Dermatol Venereol 2021;35:e730-2. [PMID: 34242422 DOI: 10.1111/jdv.17506] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
360 Leasure AC, Cowper SE, McNiff J, Cohen JM. Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34236729 DOI: 10.1111/jdv.17494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
361 Aktas H, Ertuğrul G. Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence? Clin Exp Dermatol 2021. [PMID: 34236714 DOI: 10.1111/ced.14842] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
362 Cazzato G, Romita P, Foti C, Cimmino A, Colagrande A, Arezzo F, Sablone S, Barile A, Lettini T, Resta L, Ingravallo G. Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives. Vaccines (Basel) 2021;9:760. [PMID: 34358176 DOI: 10.3390/vaccines9070760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
363 Cameli N, Silvestri M, Mariano M, Nisticò SP, Cristaudo A. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34236735 DOI: 10.1111/jdv.17500] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
364 Merhy R, Sarkis AS, Kaikati J, El Khoury L, Ghosn S, Stephan F. New-onset cutaneous lichen planus triggered by COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34236718 DOI: 10.1111/jdv.17504] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
365 Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines: What dermatologists should know? Dermatol Ther 2021;:e15056. [PMID: 34232548 DOI: 10.1111/dth.15056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
366 Mieczkowska K, Kaubisch A, McLellan BN. Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor. Dermatol Ther 2021;:e15055. [PMID: 34231301 DOI: 10.1111/dth.15055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
367 Kim JE, Lee H, Paik SS, Moon JY, Yoon HJ, Kim SH. Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'? J Eur Acad Dermatol Venereol 2021. [PMID: 34166540 DOI: 10.1111/jdv.17476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
368 Krajewski PK, Matusiak Ł, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol 2021;35:e632-4. [PMID: 34131967 DOI: 10.1111/jdv.17449] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 15.5] [Reference Citation Analysis]
369 Alflen C, Birch K, Shilian R, Wu SS, Hostoffer R Jr. Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine. Allergy Rhinol (Providence) 2021;12:21526567211026271. [PMID: 34249404 DOI: 10.1177/21526567211026271] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
370 Krüger K. [Erythema chronicum migrans-like appearance as sequel to COVID vaccination]. Z Rheumatol 2021. [PMID: 34152434 DOI: 10.1007/s00393-021-01024-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
371 Pérez-López I, Gil-Villalba A, Ruiz-Villaverde R. Perniosis-like lesions after vaccination with mRNA against COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00324-9. [PMID: 34229882 DOI: 10.1016/j.medcli.2021.05.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Kharkar V, Vishwanath T, Mahajan S, Joshi R, Gole P. Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance. Clin Exp Dermatol 2021. [PMID: 34115904 DOI: 10.1111/ced.14797] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
373 Khehra N, Padda I, Jaferi U, Atwal H, Narain S, Parmar MS. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization. AAPS PharmSciTech 2021;22:172. [PMID: 34100150 DOI: 10.1208/s12249-021-02058-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
374 Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID-19 Vaccination-Induced Rash: Does the Choice of Vaccine Matter? Cureus 2021;13:e15490. [PMID: 34268022 DOI: 10.7759/cureus.15490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
375 Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide. Dermatol Clin 2021;39:653-73. [PMID: 34556254 DOI: 10.1016/j.det.2021.05.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 22.5] [Reference Citation Analysis]
376 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021:S0001-7310(21)00203-9. [PMID: 34052201 DOI: 10.1016/j.ad.2021.05.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
377 Lacroix C, Salvo F, Gras-Champel V, Gautier S, Massy N, Valnet-Rabier MB, Grandvuillemin A, Mounier C, Benkebil M, Pariente A, Jonville-Béra AP, Micallef J; French Network of Pharmacovigilance Centres. French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge. Therapie 2021;76:297-303. [PMID: 34059351 DOI: 10.1016/j.therap.2021.05.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
378 Lopez S, Vakharia P, Vandergriff T, Freeman EE, Vasquez R. Pernio after COVID-19 vaccination. Br J Dermatol 2021;185:445-7. [PMID: 33893637 DOI: 10.1111/bjd.20404] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
379 Makhlouf M, Akl J, Ammoury A. Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines. EMJ. [DOI: 10.33590/emj/21-00254] [Reference Citation Analysis]
380 Ben Salah N, Lahouel I, Manaa L, Soua Y, Youssef M, Belhadjali H, Zili J. Herpes zoster following COVID-19 vaccination: about 2 cases. Vestnik dermatologii i venerologii 2021;98:72-4. [DOI: 10.25208/vdv1275] [Reference Citation Analysis]
381 Cernat MC, Ali S, Bumbăcea RS. Cutaneous adverse effects of COVID-19 vaccines: what do we know so far? Alergologia 2021;2:62. [DOI: 10.26416/aler.5.2.2021.4898] [Reference Citation Analysis]
382 Pandhi D, Munisamy M, Singh BTP. Recommendations for COVID vaccination for dermatological patients on immunosuppressive/immunomodulatory therapy (IADVL Academy). Indian Dermatol Online J 2021;12:4. [DOI: 10.4103/idoj.idoj_412_21] [Reference Citation Analysis]
383 Saeb Lima M, Guzmán Perera MG. Reacciones cutáneas inmediatas tardías a las vacunas para COVID-19: serie de cinco casos. Acta Médica Grupo Ángeles 2021;19:s84-90. [DOI: 10.35366/101035] [Reference Citation Analysis]